SecBot SecBot
SECBOTREPLAY Home › Report › PDSB

PDSB · PDS Biotechnology announced that NantWorks exercised warrants for…

PDS Biotechnology Corp · 8-K filed Nov 10, 2026 at 08:05 ET

At the news

NEUTRALIMPACT 4/10

8-K filed Nov 10, 2026 at 08:05 ET

PDS Biotechnology announced that NantWorks exercised warrants for 17,699,115 shares at $0.22 per share, generating approximately $3.9 million in gross proceeds. The warrants were issued in connection with a September 2026 private placement that raised $11.3 million. Proceeds will fund advancement of PDS0301 toward a Phase 3 trial and partnership strategy for PDS0101.

  • NantWorks exercised warrants to purchase 17,699,115 shares at $0.22 per share
  • Gross proceeds to PDS Biotechnology were approximately $3.9 million
  • Warrants were issued in connection with a September 14, 2026 private placement that raised $11.3 million
  • Proceeds will support advancement of PDS0301 toward a Phase 3 trial in metastatic colorectal cancer and partnership strategy for PDS0101

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access